Andros PharmaceuticalsLtd Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| VC/PE Firms | 2,540,880 | 7.31% |
| Institutions | 4,636,993 | 13.3% |
| Public Companies | 4,724,000 | 13.6% |
| General Public | 22,870,127 | 65.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 4,724,000 | NT$75.8m | 0% | no data | |||
| 2,540,880 | NT$40.8m | 0% | 5.42% | |||
| 1,622,000 | NT$26.0m | 0% | 75.94% | |||
| 1,546,993 | NT$24.8m | 0% | 0.87% | |||
| 1,468,000 | NT$23.6m | 0% | 0.05% |